Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 26703889

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Mar 5
First author
Yao JC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Mar 5;387(10022):924-926. doi: 10.1016/S0140-6736(15)01234-9.
    note
    Source null
    related pmid
    26703890
    relationship
    Comment in
  2. citation
    Lancet. 2016 Jul 16;388(10041):236. doi: 10.1016/S0140-6736(16)31039-X.
    note
    Source null
    related pmid
    27479567
    relationship
    Comment in
  3. citation
    Lancet. 2016 Jul 16;388(10041):236-7. doi: 10.1016/S0140-6736(16)31045-5.
    note
    Source null
    related pmid
    27479568
    relationship
    Comment in

Authors and identifiers

  1. name
    Yao JC
    type
    Author
  2. name
    Fazio N
    type
    Author
  3. name
    Singh S
    type
    Author
  4. name
    Buzzoni R
    type
    Author
  5. name
    Carnaghi C
    type
    Author
  6. name
    Wolin E
    type
    Author
  7. name
    Tomasek J
    type
    Author
  8. name
    Raderer M
    type
    Author
  9. name
    Lahner H
    type
    Author
  10. name
    Voi M
    type
    Author
  11. name
    Pacaud LB
    type
    Author
  12. name
    Rouyrre N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Yao JC
    type
    Author
  2. name
    Fazio N
    type
    Author
  3. name
    Singh S
    type
    Author
  4. name
    Buzzoni R
    type
    Author
  5. name
    Carnaghi C
    type
    Author
  6. name
    Wolin E
    type
    Author
  7. name
    Tomasek J
    type
    Author
  8. name
    Raderer M
    type
    Author
  9. name
    Lahner H
    type
    Author
  10. name
    Voi M
    type
    Author
  11. name
    Pacaud LB
    type
    Author
  12. name
    Rouyrre N
    type
    Author
bibliography ids
  1. nci-bib-a5441ff93d7fc53d0cd8e78a
book metadata
content sha256
72e236174d45a7d35085b1112380364ed1763b5d63cccae0434ad591546c255f
document type
citation
dois
  1. 10.1016/S0140-6736(15)00817-X
electronic publication date
display
2015 Dec 17
precision
day
year
2015
evidence scope
bibliographic_metadata_only
id
pubmed:26703889
immutable id
pubmed:26703889@72e236174d45a7d35085b1112380364ed1763b5d63cccae0434ad591546c255f
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10022
name
Lancet (London, England)
nlm unique id
2985213R
pages
968-977
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Mar 5;387(10022):924-926. doi: 10.1016/S0140-6736(15)01234-9.
    note
    Source null
    related pmid
    26703890
    relationship
    Comment in
  2. citation
    Lancet. 2016 Jul 16;388(10041):236. doi: 10.1016/S0140-6736(16)31039-X.
    note
    Source null
    related pmid
    27479567
    relationship
    Comment in
  3. citation
    Lancet. 2016 Jul 16;388(10041):236-7. doi: 10.1016/S0140-6736(16)31045-5.
    note
    Source null
    related pmid
    27479568
    relationship
    Comment in
outcomes validated
false
pmid
26703889
provenance
batch id
948d34b0dea86780a31d
provider
NCBI PubMed ESummary
record sha256
aec4f3ede3606e2b568ef97fe7e763ac3531d927f3067bbd260380e64a63156a
response sha256
11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
retrieved at
2026-09-09T23:47:15.495091+00:00
publication date
display
2016 Mar 5
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/26703889/
title
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Preserved source evidence · Not medical advice